Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by jdstoxon Aug 29, 2017 9:27pm
147 Views
Post# 26635123

RE:RE:RE:RE:Information circular...

RE:RE:RE:RE:Information circular...What part of the process to manufacture clinical grade proteins are you asking about, jekyl? What do you mean by "begun the process?"

And if that part of the process was revealed to you, would you understand where, chronologically, that would place that part of the process?

Better, just answer this. What is the "process to manufacture clinical grade proteins?" You know, the critical path of such a project. Clearly you know the answer to this or there would be no point in asking the question.

Explain that process to us, so that we all might ponder it.

Money?

Good question.

It's like living, jekyl. We all know that to live another year, we will need food, shelter, money, but none of us knows for sure where it will come from. Do we expect to starve in the next year? Do we still set objectives? 

Or do we just admit that it's all to scary and tough, and give up.

As usual, jekyl, you can do better, as I'm sure you do in real life.

jd
Bullboard Posts